Cytogenetic abnormalities associated with the t(12;21): A collaborative study of 169 children with t(l2;21)-positive acute lymphoblastic leukemia

Leukemia

Volumn 13, Issue 9, 1999, Pages 1325-1330

  Raynaud, S D ^a,d   Dastugue, N ^b   Zoccola, D ^a   Shurtleff, S A ^c   Mathew, S ^c   Raimondi, S C ^c  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CHU PURPAN   (France)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d CNRS/UNSA UMR 6549   (France)

Author keywords

Childhood acute lymphoblastic leukemia; Cytogenetics; t(12; 21)

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; CHROMOSOME 12P; CHROMOSOME 21; CHROMOSOME 6; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032841521     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401506     Document Type: Article

References (31)

1. Solomon E, Borrow J, Goddard AD. Chromosome aberrations and cancer. Science 1991; 254: 1153-1160.
2. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81: 2237-2251.
3. Pui C-H, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1449-1463.
4. Romana SP, Le Conniat M, Berger R. t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosom Cancer 1994; 9: 186-191.
5. Romana SP, Poirel H, Leconiat M, Flexor MA, Machauffe M, Jonveaux P, Macintyre E, Berger R, Bernard OA. High frequency of the t(12;21) in childhood in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263-4269.
6. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC-F, Pui C-H, Grosveld G, Downing JR. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985-1989.
7. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen J, Seriu T, Bartram CR, Sallan SE, Gilliland G, Golub TR. TEL-AML1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 1996; 88: 4252-4258.
8. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of the PDGF receptor ßto a novel est-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77: 307-316.
9. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG. Fusion of the TEL gene on 12p13 tp the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995; 92: 4917-4921.
10. Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood 1995; 85: 3662-3670.
11. Raynaud S, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996; 87: 2891-2899.
12. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. Incidence of TEL-AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 1997; 90: 4933-4937.
13. Chambost H, Michel G, Thuret I, Toiron Y, Brunet C, Capodano AM, Perrimond H, Gabert J. TEL/AML1 transcript may not be an independent prognostic factor in childhood acute lymphoblastic leukemia. Blood 1996; 88 (Suppl. 1): 72a (Abstr.).
14. Rivera GK, Raimondi SC, Hancock ML, Behm F, Pui C-H, Abromowitch M, Mirro J Jr, Ochs J, Look AT, Williams DL, Murphy SB, Dahl GV, Kalwinsky DK, Evans WE, Kun LE, Simone JV, Crist WM. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61-66.
15. Pui C-H, Simone JV, Hancock ML, Evans WE, Williams DL, Bowman LP, Dahl GV, Dodge RK, Ochs J, Abromowitch M, Rivera GK. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude Total Therapy Study X. Leukemia 1992; 6: 150-157.
16. Cavé H, van der Werff ten Bosch J, Succiu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. New Engl J Med 1998; 339: 591-598.
17. Williams DL, Harris A, Williams KJ, Brosius MJ, Lemonds W. A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 1984; 13: 239-257.
18. ISCN 1991 Mikelman F (ed). Guidelines for Cancer Cytogenetics: Supplement to An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 1991.
19. Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen J, Camitta BM, Pui C, Downing JR, Behm FG. Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group Study. Blood 1997; 89: 1143-1146.
20. Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter KS, Reynolds C, Sklar J, Donnelly M, Bohlander SK, Rowley JD, Gilliland DG, Golub TR. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia in childhood. Blood 1995; 86: 38-44.
21. Cavé H, Cacheux V, Raynaud S, Brunie G, Bakkus M, Cochaux P, Preudhomme C, Laï JL, Vilmer E, Grandchamp B. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphoblastic leukemia. Leukemia 1997; 11: 1459-1464.
22. Vogelstein B, Kinzler KW. The multiple nature of cancer. Trends Genet 1993; 9: 138-141.
23. Kim DH, Moldwin RL, Vignon C, Bohlander C, Suto Y, Giordano L, Gupta R, Fears S, Nucifora G, Rowley J, Smith SD. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 1996; 88: 785-794.
24. Maloney K, McGavran L, Odom LF, Hunger SP. Acquisition of p16INK4A and p15INK4B gene abnormalities between initial diagnosis of relapse in children with acute lymphoblastic leukemia. Blood 1999; 93: 2380-2385.
25. Ford AM, Bennett CA, Price CM, Bruin MC, Van Wering ER, Greaves M. Fetal origins of the TEL AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 1998; 95: 4584-4588.
26. Wiemels JL, Ford AM, Bennett CA, Saha V, Jones L, Young BD, Greaves MF. Direct evidence for a pre-natal origin of TEL-AML1 gene fusions in pediatric leukemia. Blood 1998; 92 (Suppl. 1): 277a (Abstr.).
27. Chase A, Reiter A, Burci L, Cazzaniga G, Biondi A, Pickard J, Roberts IAG, Goldman JM, Cross NCP. ETV6 is fused to the homeobox gene CDX2 in a patient with acute myeloid leukemia and a t(12;13)(p13 ;q12). Blood 1998; 92 (Suppl. 1): 284a (Abstr.).
28. Coignet LJ, Lima SCP, Min T, Streubel B, Swansbury J, Telford N, Swanton S, Bowen A, Nagai M, Catovsky D, Fonatsch C, Dyer M. Myeloid and lymphoispecific breakpoint cluster regions in chromosome 13q14 in acute leukemia. Blood 1998; 92 (Suppl. 1): 288a (Abstr.).
29. Loncarevic IF, Roltzheim B, Ritterbach J, Viehmann S, Borkhardt A, Lampert F, Harbott J. Trisomy 21 is a recurrent scondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion. Genes Chromosom Cancer 1999; 24: 272-277.
30. Fears S, Vignon C, Bohlander SK, Smith S, Rowley JD, Nucifora G. Correlation between the ETV6/CBFA2 (TEL/AML1) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemia. Genes Chromosom Cancer 1996; 17: 127-135.
31. Hiebert SW, Sun WII, Davis JN, Golub T, Shurtleff SA, Buijs A, Downing JR, Grosveld G, Roussel MF, Gilliland DG, Lenny N, Meyers S. The t(12;21) translocation converts AML-1B from an activator to a represser of transcription. Mol Cell Biol 1996; 16: 1349-1355.